- Home
- XFOR vs FTCI Comparison
XFOR vs FTCI Comparison
Compare XFOR & FTCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XFOR
- FTCI
- Stock Information
- Founded
- XFOR 2014
- FTCI 2017
- Country
- XFOR United States
- FTCI United States
- Employees
- XFOR N/A
- FTCI N/A
- Industry
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- FTCI Semiconductors
- Sector
- XFOR Health Care
- FTCI Technology
- Exchange
- XFOR Nasdaq
- FTCI Nasdaq
- Market Cap
- XFOR 84.3M
- FTCI 93.0M
- IPO Year
- XFOR N/A
- FTCI 2021
- Fundamental
- Price
- XFOR $3.80
- FTCI $8.68
- Analyst Decision
- XFOR Strong Buy
- FTCI Buy
- Analyst Count
- XFOR 3
- FTCI 3
- Target Price
- XFOR $34.17
- FTCI $4.67
- AVG Volume (30 Days)
- XFOR 1.5M
- FTCI 60.8K
- Earning Date
- XFOR 11-12-2025
- FTCI 11-05-2025
- Dividend Yield
- XFOR N/A
- FTCI N/A
- EPS Growth
- XFOR N/A
- FTCI N/A
- EPS
- XFOR N/A
- FTCI N/A
- Revenue
- XFOR $32,774,000.00
- FTCI $64,134,000.00
- Revenue This Year
- XFOR $1,307.51
- FTCI $90.77
- Revenue Next Year
- XFOR N/A
- FTCI $130.32
- P/E Ratio
- XFOR N/A
- FTCI N/A
- Revenue Growth
- XFOR 5721.31
- FTCI N/A
- 52 Week Low
- XFOR $1.35
- FTCI $2.13
- 52 Week High
- XFOR $26.83
- FTCI $9.50
- Technical
- Relative Strength Index (RSI)
- XFOR 62.57
- FTCI 56.87
- Support Level
- XFOR $2.96
- FTCI $7.42
- Resistance Level
- XFOR $4.54
- FTCI $9.50
- Average True Range (ATR)
- XFOR 0.26
- FTCI 0.69
- MACD
- XFOR 0.08
- FTCI -0.01
- Stochastic Oscillator
- XFOR 57.47
- FTCI 62.16
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.